Birchview Capital, LP Castle Biosciences Inc Transaction History
Birchview Capital, LP
- $111 Million
- Q1 2025
A detailed history of Birchview Capital, LP transactions in Castle Biosciences Inc stock. As of the latest transaction made, Birchview Capital, LP holds 88,404 shares of CSTL stock, worth $1.71 Million. This represents 1.59% of its overall portfolio holdings.
Number of Shares
88,404
Previous 78,000
13.34%
Holding current value
$1.71 Million
Previous $2.08 Million
14.87%
% of portfolio
1.59%
Previous 1.77%
Shares
10 transactions
Others Institutions Holding CSTL
# of Institutions
188Shares Held
26.8MCall Options Held
9.5KPut Options Held
5K-
Black Rock Inc. New York, NY3.04MShares$59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$39.6 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.8MShares$34.8 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.27MShares$24.5 Million2.07% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.2MShares$23.2 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $509M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...